1451 studies found for:    "Hepatitis C"
Show Display Options
Download search resultsDownload the search results for:
"Hepatitis C" (1451 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Enrolling by invitation A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
2 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
3 Completed Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
Conditions: Hepatitis C;   Chronic Hepatitis C
Interventions: Other: Mailer;   Other: In-person recruitment;   Other: EHR Alert
4 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
5 Active, not recruiting A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Not yet recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
7 Not yet recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
8 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir
9 Recruiting A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-450/r;   Drug: ABT-530;   Drug: Ribavirin (RBV)
10 Active, not recruiting A Study to Evaluate the Safety and Effect of ABT-450, Ritonavir and ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis
Conditions: Chronic Hepatitis C;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
11 Terminated Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Drug: GSK625433/placebo
12 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
13 Withdrawn A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Conditions: Hepatitis C;   Hepatitis C Virus
Interventions: Drug: Fluvastatin;   Drug: Peginterferon alfa2a;   Drug: ribavirin
14 Completed A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Conditions: Chronic Hepatitis C;   Hepatitis C;   Hepatitis C Virus (HCV)
Interventions: Drug: ABT-450/r;   Drug: ABT-333;   Drug: ribavirin
15 Terminated
Has Results
Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)
Conditions: Hepatitis C;   Hepatitis C, Chronic
Interventions: Biological: Peg-IFN alfa-2b;   Drug: Ribavirin
16 Completed Hepatitis C Treatment and Atherosclerosis
Conditions: Chronic Hepatitis C;   Atherosclerosis
Intervention:
17 Completed
Has Results
Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) injector;   Drug: Rebetol (ribavirin; SCH 18908)
18 Completed
Has Results
Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) pen;   Drug: Rebetol (ribavirin; SCH 18908)
19 Completed
Has Results
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: PegIntron (Peginterferon alfa-2b);   Drug: Rebetol (Ribavirin)
20 Terminated Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: IntronA (interferon alfa-2b; SCH 30500);   Drug: Rebetol (ribavirin; SCH 18908)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years